ElevateBio names AlloVir as its first portfolio company

A company set up to take biomedical research from academia and build companies around it has revealed its first portfolio company. ElevateBio, a Cambridge, Massachusetts-based holding company...

Facebook rolls out new disease prevention mapping tools

Social media giant Facebook is launching new mapping features meant to give health organizations real-time visibility into on-the-ground health situations. The company is releasing three types of...

An inside look at UnityPoint Health’s new partnership with startups

Many health systems have created teams to invest in startups and commercialize their own technology, either to scale it within their own institutions or offer it...

Nightware receives breakthrough designation for its PTSD nightmare therapy technology

Oftentimes individuals suffering from post-traumatic stress disorder experience severe nightmares where they relive horrible experiences from their past over and over again. These kinds of nightmare disorders...

After Walmart, Mayo pushes further into workplace health

Rochester, Minnesota-based Mayo Clinic already has a Centers of Excellence program with Walmart, but through a new collaboration, it is making another move into the workplace health...

Alphabet’s Verily boosts its Project Baseline with new health system, pharma partners

Alphabet’s Verily life science division launched its Project Baseline back in 2017 with the ambition to make it easier for individuals to get involved in the...

Merck’s Keytruda fails in Phase III triple-negative breast cancer study, but has a few...

A clinical trial of Merck & Co.’s flagship oncology drug in a form of breast cancer has failed. However, the company is also running additional trials...

Nashville healthcare innovation fund Jumpstart Foundry adds 15 startups to its portfolio

Jumpstart Foundry, a Nashville, Tennessee-based seed stage healthcare innovation fund, has selected 15 startups for its 2019 cohort. The companies have footholds in the ambulatory, hospital,...

New antibiotics are urgently needed, but economics stand in the way

On March 10, 2017, shares of antibiotic developer Achaogen traded at $27 on the Nasdaq. Two years later, it has become a penny stock trading at around...

Cala Health raises $50M ahead of commercial launch of its bioelectric stimulation device

The Burlingame, California-based startup bills itself as a bioelectric medicine company that is using electric signals to stimulate the nervous system as a pathway to treat...

Must Read